Genetic Architecture of Untargeted Lipidomics in Cardiometabolic-Disease Patients Combines Strong Polygenic Control and Pleiotropy.

Brial, Francois; Hedjazi, Lyamine; Sonomura, Kazuhiro; Al Hageh, Cynthia; Zalloua, Pierre; Matsuda, Fumihiko; Gauguier, Dominique.

Afiliação

Brial F; Center for Genomic Medicine, Graduate School of Medicine Kyoto University, Kyoto 606-8501, Japan.
Hedjazi L; INSERM UMR 1124, Université Paris Cité, 45 rue des Saint-Pères, 75006 Paris, France.
Sonomura K; Beemetrix SAS, 30 Avenue Carnot, 91300 Massy, France.
Al Hageh C; Life Science Research Center, Technology Research Laboratory, Shimadzu Corporation, Kyoto 606-8501, Japan.
Zalloua P; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi P.O. Box 17666, United Arab Emirates.
Matsuda F; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi P.O. Box 17666, United Arab Emirates.
Gauguier D; Center for Genomic Medicine, Graduate School of Medicine Kyoto University, Kyoto 606-8501, Japan.

Metabolites ; 12(7)2022 Jun 27.

Article em En | MEDLINE | ID: mdl-35888720